Movatterモバイル変換

Jump to content

methotrexate(Q422232)

From Wikidata

chemical compound

amethopterin
4-amino-10-methylfolic acid
4-amino-N(10)-methylpteroylglutamic acid
MTX
N-(4-{[(2,4-diamino-6-pteridinyl)methyl]methylamino}benzoyl)-L-glutamic acid

Language	Label	Description	Also known as
default for all languages	No label defined
English	methotrexate	chemical compound	amethopterin 4-amino-10-methylfolic acid 4-amino-N(10)-methylpteroylglutamic acid MTX N-(4-{[(2,4-diamino-6-pteridinyl)methyl]methylamino}benzoyl)-L-glutamic acid

Statements

type of chemical entity

0 references

1 reference

based on heuristic

inferred from InChIKey

cellular response to methotrexate

subject has role

1 reference

Gene Ontology release 2019-11-16

methotrexate transmembrane transporter activity

subject has role

1 reference

Gene Ontology release 2019-11-16

response to methotrexate

subject has role

1 reference

Gene Ontology release 2020-05-02

0 references

chemical structure

Methotrexate2DACS2.svg
708 × 337; 20 KB

1 reference

imported from Wikimedia project

English Wikipedia

stereoisomer of

(R)-methotrexate

2 references

based on heuristic

inferred from InChIKey

based on heuristic

inferred from InChI

chemical formula

C₂₀H₂₂N₈O₅

1 reference

language of work or name

methotrexate(English)

19 November 2016

canonical SMILES

CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O

1 reference

language of work or name

methotrexate(English)

19 November 2016

isomeric SMILES

CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O

1 reference

language of work or name

methotrexate(English)

19 November 2016

defined daily dose

2.5milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=L04AX03

active ingredient in

1 reference

European Medicines Agency product number

EMEA/H/C/003983

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003983/human_med_002015.jsp

22 March 2017

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

methotrexate(English)

1 reference

language of work or name

methotrexate(English)

19 October 2016

1 reference

Detection and quantification of maitotoxin-like compounds using a neuroblastoma (Neuro-2a) cell based assay. Application to the screening of maitotoxin-like compounds in Gambierdiscus spp

Asimina triloba

1 reference

Antiangiogenic Activity and Chemical Derivatization of the Neurotoxic Acetogenin Annonacin Isolated from Asimina triloba

Quambalaria cyanescens

1 reference

Quambalarine B, a Secondary Metabolite from Quambalaria cyanescens with Potential Anticancer Properties

Dolichousnea longissima

1 reference

Usnic Acid Derivatives with Cytotoxic and Antifungal Activities from the Lichen Usnea longissima.

medical condition treated

head and neck cancer

1 reference

language of work or name

13 December 2016

spindle cell sarcoma

1 reference

language of work or name

13 December 2016

1 reference

language of work or name

13 December 2016

trophoblastic neoplasm

1 reference

language of work or name

13 December 2016

esophageal cancer

1 reference

language of work or name

13 December 2016

rheumatoid arthritis

1 reference

language of work or name

13 December 2016

juvenile rheumatoid arthritis

1 reference

language of work or name

13 December 2016

1 reference

language of work or name

13 December 2016

mycosis fungoides

2 references

language of work or name

13 December 2016

Drug Indications Extracted from FAERS

2 October 2018

lung benign neoplasm

1 reference

language of work or name

13 December 2016

testicular cancer

1 reference

language of work or name

13 December 2016

2 references

language of work or name

13 December 2016

Drug Indications Extracted from FAERS

2 October 2018

1 reference

language of work or name

13 December 2016

2 references

language of work or name

13 December 2016

Drug Indications Extracted from FAERS

2 October 2018

1 reference

language of work or name

13 December 2016

1 reference

Drug Indications Extracted from FAERS

2 October 2018

ankylosing spondylitis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

precursor T-cell lymphoblastic leukemia

1 reference

Drug Indications Extracted from FAERS

2 October 2018

granulomatosis with polyangiitis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

acute myeloid leukemia

1 reference

Drug Indications Extracted from FAERS

2 October 2018

precursor T-cell acute lymphoblastic leukemia

1 reference

Drug Indications Extracted from FAERS

2 October 2018

ectopic pregnancy

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

diffuse large B-cell lymphoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

T-cell lymphoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

polymyalgia rheumatica

1 reference

Drug Indications Extracted from FAERS

2 October 2018

ulcerative colitis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

non-Hodgkin lymphoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

acute promyelocytic leukemia

1 reference

Drug Indications Extracted from FAERS

2 October 2018

B-cell lymphoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

osteoarthritis susceptibility 1

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

giant cell arteritis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

systemic-onset juvenile idiopathic arthritis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

central nervous system lymphoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

precursor B-cell acute lymphoblastic leukemia

1 reference

Drug Indications Extracted from FAERS

2 October 2018

bullous pemphigoid

1 reference

Drug Indications Extracted from FAERS

2 October 2018

significant drug interaction

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bone marrow failure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sulfamethoxazole

bone marrow failure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

megaloblastic anemia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bone marrow toxicity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sulfamethoxazole

megaloblastic anemia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sulfamethoxazole

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

sulfamethoxazole

bone marrow toxicity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

solute carrier family 46 member 1

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

solute carrier family 19 member 1

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

route of administration

oral administration

0 references

intravenous infusion and defusion

0 references

intramuscular injection

0 references

intrathecal administration

0 references

legal status (medicine)

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.(English)

pregnancy category

Australian pregnancy category D

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category X

1 reference

imported from Wikimedia project

English Wikipedia

1 reference

https://www.pfizer.com/products/product-list

454.171dalton

1 reference

language of work or name

methotrexate(English)

19 October 2016

subject has role

1 reference

5 March 2018

disease-modifying antirheumatic drug

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

enzyme inhibitor

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

Abortifacient Agents, Nonsteroidal

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

antineoplastic antimetabolite

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

dermatologic drug

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

folic acid antagonists

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

immunosuppressive drug

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

DNA polymerase inhibitors

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

essential medicine

0 references

developmental toxicant

1 January 1989

1 reference

California Proposition 65 list of chemicals

18 March 2020

https://oehha.ca.gov/chemicals/methotrexate

Commons category

Methotrexate

0 references

Identifiers

0 references

National Library of Israel J9U ID

987007529313305171

1 reference

National Library of Israel

Library of Congress authority ID

subject named as

Methotrexate

1 reference

Integrated Authority File

InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1

1 reference

language of work or name

methotrexate(English)

19 November 2016

FBOZXECLQNJBKD-ZDUSSCGKSA-N

2 references

language of work or name

methotrexate(English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

methotrexate(English)

19 November 2016

FBOZXECLQNJBKD-ZDUSSCGKSA-N

CAS Common Chemistry

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=59-05-2

1 reference

language of work or name

Methotrexate(English)

19 November 2016

2 references

language of work or name

methotrexate(English)

19 November 2016

matched by identifier from

FBOZXECLQNJBKD-ZDUSSCGKSA-N

Reaxys registry number

70669

0 references

mapping relation type

3 references

language of work or name

METHOTREXATE(English)

19 November 2016

ChEBI release 2019-10-02

matched by identifier from

International Chemical Identifier

InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1

1 reference

language of work or name

METHOTREXATE(English)

19 November 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

FBOZXECLQNJBKD-ZDUSSCGKSA-N

UniChem compound ID

1 reference

MassBank accession ID

MSBNK-Athens_Univ-AU273001

1 reference

FBOZXECLQNJBKD-ZDUSSCGKSA-N

MassBank/MassBank-data: release version 2022.06 to wikidata

4 September 2022

based on heuristic

MSBNK-Athens_Univ-AU273002

1 reference

FBOZXECLQNJBKD-ZDUSSCGKSA-N

MassBank/MassBank-data: release version 2022.06 to wikidata

4 September 2022

based on heuristic

MSBNK-Athens_Univ-AU273004

1 reference

FBOZXECLQNJBKD-ZDUSSCGKSA-N

MassBank/MassBank-data: release version 2022.06 to wikidata

4 September 2022

based on heuristic

MSBNK-Athens_Univ-AU273006

1 reference

FBOZXECLQNJBKD-ZDUSSCGKSA-N

MassBank/MassBank-data: release version 2022.06 to wikidata

4 September 2022

based on heuristic

MSBNK-Athens_Univ-AU273005

1 reference

FBOZXECLQNJBKD-ZDUSSCGKSA-N

MassBank/MassBank-data: release version 2022.06 to wikidata

4 September 2022

based on heuristic

MSBNK-Athens_Univ-AU273003

1 reference

FBOZXECLQNJBKD-ZDUSSCGKSA-N

MassBank/MassBank-data: release version 2022.06 to wikidata

4 September 2022

based on heuristic

splash10-0fai-6900000000-25b0e287457fb3845ef4

0 references

CAMEO Chemicals ID

0 references

0 references

1 reference

Hazardous Substances Data Bank

publication date

28 October 2019

METHOTREXATE(English)

10 May 2021

DSSTox substance ID

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

matched by identifier from

FBOZXECLQNJBKD-ZDUSSCGKSA-N

DSSTOX compound identifier

0 references

0 references

1 reference

Global Substance Registration System

language of work or name

methotrexate(English)

19 November 2016

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Methotrexate(English)

CAS no.: 59-05-2(English)

OSHA Occupational Chemical Database ID

0 references

1 reference

CosIng database

28 December 2019

METHOTREXATE(English)

CAS no.: 59-05-2(English)

1 reference

language of work or name

Methotrexate(English)

publication date

17 November 2015

1 reference

language of work or name

Methotrexate(English)

publication date

17 November 2015

National Drug Code

0 references

0 references

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

methotrexate(English)

19 November 2016

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

MeSH descriptor ID

subject named as

Methotrexate

0 references

MeSH concept ID

0 references

D03.633.100.733.631.192.500

broader concept

0 references

1 reference

Global Substance Registration System

language of work or name

methotrexate(English)

19 November 2016

1 reference

matched by identifier from

FBOZXECLQNJBKD-ZDUSSCGKSA-N

Human Metabolome Database ID

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

FBOZXECLQNJBKD-ZDUSSCGKSA-N

2 references

Global Substance Registration System

language of work or name

methotrexate(English)

19 November 2016

matched by identifier from

FBOZXECLQNJBKD-ZDUSSCGKSA-N

MedlinePlus drug identifier

route of administration

oral administration

0 references

route of administration

0 references

PatientsLikeMe treatment ID

0 references

1 reference

Global Substance Registration System

language of work or name

methotrexate(English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

methotrexate(English)

19 October 2016

IEDB Epitope ID

1 reference

Immune Epitope Database and Analysis Resource

IEDB Epitope ID

1 March 2022

0 references

1 reference

California Proposition 65 list of chemicals

6 January 2020

https://oehha.ca.gov/chemicals/methotrexate

0 references

electronic Essential Medicines List medicine ID

1 reference

https://list.essentialmeds.org/medicines/99

eEML - Electronic Essential Medicines List(English)

23 October 2021

Encyclopædia Britannica Online ID

science/methotrexate

subject named as

methotrexate

0 references

1 reference

Freebase Data Dumps

publication date

28 October 2013

Gran Enciclopèdia Catalana ID

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0 references

Microsoft Academic ID (discontinued)

0 references

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

PDB structure ID

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DLS(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1RB3(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2OIP(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4L8F(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4L8W(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1D1G(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DF7(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1RH3(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1RX3(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1E7W(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4Q0D(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3TQ9(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3IX9(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DHJ(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DHI(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2C7V(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4DFR(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4GH8(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1TDR(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3CL9(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4P66(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4P68(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1RG7(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3DFR(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4QI9(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4KY8(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2DRC(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DDS(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DDR(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4L6H(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3HJ3(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3DAT(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3DAU(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1MXF(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3QXT(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3QXV(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3IA4(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1RA3(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DRA(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DRB(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1DRE(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4KN0(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2QK8(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1P33(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1U72(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1U70(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3DRC(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

5J7W(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

5HI6(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3EIG(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1AO8(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

1AXW(English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3CD2(English)

19 October 2016

1 reference

Römpp online ID

1 reference

imported from Wikimedia project

German Wikipedia

Store medisinske leksikon ID

mapping relation type

subject named as

metotreksat

1 reference

Great Norwegian Encyclopedia

30 May 2020

UK Parliament thesaurus ID

subject named as

Methotrexate

0 references

1 reference

Global Substance Registration System

language of work or name

methotrexate(English)

19 November 2016

WikiProjectMed ID

0 references

WikiSkripta article ID

0 references

WordNet 3.1 Synset ID

1 reference

concept/0ec2699c-0443-4233-9d12-52a8c8cc355c

0 references

Sitelinks

Wikipedia(41 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswikiCategory:Methotrexate

Retrieved from "https://www.wikidata.org/w/index.php?title=Q422232&oldid=2462497284"

[8]ページ先頭

©2009-2026 Movatter.jp